Potential health impacts and costs of active case finding guided by <i>Mycobacterium tuberculosis</i> immunoreactivity survey results in Blantyre, Malawi: A mathematical modeling study

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

by Sun Kim, Melike Hazal Can, Hannah M. Rickman, Mphatso D. Phiri, Marriott Nliwasa, Tisungane E. Mwenyenkulu, Kuzani Mbendera, Stéphane Verguet, Marcia C.

Castro, Elizabeth L. Corbett, Peter MacPherson, Ted Cohen, Nicolas A. Menzies Background Active case finding (ACF) for tuberculosis (TB) can reduce transmission, yet efficient targeting requires high-quality surveillance data. We investigated the potential costs and impact of targeted ACF, guided by local estimates of the annual risk of TB infection (ARTI) derived from Mycobacterium tuberculosis (Mtb) immunoreactivity survey data…

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: PLOS Medicine · October 7, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.